mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy
Authors
Keywords
-
Journal
Cell Reports Medicine
Volume 4, Issue 3, Pages 100978
Publisher
Elsevier BV
Online
2023-03-18
DOI
10.1016/j.xcrm.2023.100978
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
- (2022) Robbie G. Majzner et al. NATURE
- Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
- (2022) Yared Hailemichael et al. CANCER CELL
- Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors
- (2022) Leonid Cherkassky et al. CANCER CELL
- Metabolic programs tailor T cell immunity in viral infection, cancer, and aging
- (2022) Sofie Hedlund Møller et al. Cell Metabolism
- Structural basis of human IL-18 sequestration by the decoy receptor IL-18 binding protein in inflammation and tumor immunity
- (2022) Sam Detry et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The IL-1 family in tumorigenesis and antitumor immunity
- (2022) Runzi Sun et al. SEMINARS IN CANCER BIOLOGY
- Novel strategies exploiting interleukin-12 in cancer immunotherapy
- (2022) Assunta Cirella et al. PHARMACOLOGY & THERAPEUTICS
- Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8+ T cells eradicates peritoneal metastases in mouse models
- (2022) Claudia Augusta Di Trani et al. OncoImmunology
- Interventional radiology for local immunotherapy in oncology
- (2021) Lambros Tselikas et al. CLINICAL CANCER RESEARCH
- Intratumoural administration and tumour tissue targeting of cancer immunotherapies
- (2021) Ignacio Melero et al. Nature Reviews Clinical Oncology
- A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
- (2021) Prasad S Adusumilli et al. Cancer Discovery
- CARs and beyond: tailoring macrophage-based cell therapeutics to combat solid malignancies
- (2021) Shifaa M. Abdin et al. Journal for ImmunoTherapy of Cancer
- IFNγ Signaling in Natural and Therapy-Induced Antitumor Responses
- (2021) Alex Martínez-Sabadell et al. CLINICAL CANCER RESEARCH
- The role of Th22 cells, from tissue repair to cancer progression
- (2021) Hassan Doulabi et al. CYTOKINE
- Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants
- (2021) Enrique Conde et al. Journal for ImmunoTherapy of Cancer
- Central Role of the Antigen-Presentation and Interferon-γ Pathways in Resistance to Immune Checkpoint Blockade
- (2021) Annette Paschen et al. Annual Review of Cancer Biology-Series
- Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms
- (2020) Iñaki Etxeberria et al. Cellular & Molecular Immunology
- Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy
- (2020) Dylan J. Drakes et al. Cancer Immunology Research
- IL-15 in the Combination Immunotherapy of Cancer
- (2020) Thomas A. Waldmann et al. Frontiers in Immunology
- Cell death induced by cytotoxic CD8+T cells is immunogenic and primes caspase-3–dependent spread immunity against endogenous tumor antigens
- (2020) Paula Jaime-Sanchez et al. Journal for ImmunoTherapy of Cancer
- Cellular cytotoxicity is a form of immunogenic cell death
- (2020) Luna Minute et al. Journal for ImmunoTherapy of Cancer
- IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy
- (2020) Ting Zhou et al. NATURE
- Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells
- (2020) May Daher et al. BLOOD
- Phase I study of lentiviral-transduced chimeric antigen receptor modified T cells recognizing mesothelin in advanced solid cancers
- (2019) Andrew R. Haas et al. MOLECULAR THERAPY
- T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
- (2019) Stacey L. Doran et al. JOURNAL OF CLINICAL ONCOLOGY
- MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers
- (2019) Lirong Peng et al. Cancer Medicine
- Metabolic Consequences of T-cell Costimulation in Anticancer Immunity
- (2019) Alvaro Teijeira et al. Cancer Immunology Research
- Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells
- (2019) Iñaki Etxeberria et al. CANCER CELL
- The tolerogenic role of IFN-γ
- (2018) Primož Rožman et al. CYTOKINE & GROWTH FACTOR REVIEWS
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients
- (2018) Aung Naing et al. CANCER CELL
- A phase II study of tumor-infiltrating lymphocyte therapy for human papillomavirus-associated epithelial cancers
- (2018) Sanja Stevanovic et al. CLINICAL CANCER RESEARCH
- T-cell trafficking plays an essential role in tumor immunity
- (2018) Daniel J. Aires et al. LABORATORY INVESTIGATION
- Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment
- (2017) Oladapo O. Yeku et al. Scientific Reports
- Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
- (2017) Biliang Hu et al. Cell Reports
- Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
- (2016) Oladapo O. Yeku et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma
- (2015) L. Zhang et al. CLINICAL CANCER RESEARCH
- Adoptive T-cell therapy for cancer: The era of engineered T cells
- (2015) Chiara Bonini et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
- (2015) Aaron P Rapoport et al. NATURE MEDICINE
- Orchestrating high-throughput genomic analysis with Bioconductor
- (2015) Wolfgang Huber et al. NATURE METHODS
- Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
- (2015) Bettina Weigelin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune Response Regulation in the Tumor Microenvironment by Hypoxia
- (2015) Sara Labiano et al. SEMINARS IN ONCOLOGY
- miR-155 releases the brakes on antitumor T cells
- (2015) Yun Ji et al. OncoImmunology
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- CD103+ Dendritic Cells Producing Interleukin-12 in Anticancer Immunosurveillance
- (2014) Laurence Zitvogel et al. CANCER CELL
- Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors
- (2014) Diego O. Croci et al. CELL
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Cutting Edge: Priming of NK Cells by IL-18
- (2014) J. Chaix et al. JOURNAL OF IMMUNOLOGY
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Enhanced Effector Responses in Activated CD8+ T Cells Deficient in Diacylglycerol Kinases
- (2013) M. J. Riese et al. CANCER RESEARCH
- The IL-18 Antagonist IL-18-Binding Protein Is Produced in the Human Ovarian Cancer Microenvironment
- (2013) G. Carbotti et al. CLINICAL CANCER RESEARCH
- MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
- (2013) Jan C. Dudda et al. IMMUNITY
- Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma
- (2013) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin-18, more than a Th1 cytokine
- (2013) Daniela Novick et al. SEMINARS IN IMMUNOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Marginating Dendritic Cells of the Tumor Microenvironment Cross-Present Tumor Antigens and Stably Engage Tumor-Specific T Cells
- (2012) John J. Engelhardt et al. CANCER CELL
- Exploiting the Mutanome for Tumor Vaccination
- (2012) J. C. Castle et al. CANCER RESEARCH
- CD8 T Cell Priming in the Presence of IFN- Renders CTLs with Improved Responsiveness to Homeostatic Cytokines and Recall Antigens: Important Traits for Adoptive T Cell Therapy
- (2012) S. Hervas-Stubbs et al. JOURNAL OF IMMUNOLOGY
- Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer
- (2011) Claude Condé et al. BIOCHEMICAL PHARMACOLOGY
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
- (2011) Takami Sato et al. IMMUNOLOGIC RESEARCH
- IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells
- (2011) Daniel T. Fisher et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
- (2011) Sid P. Kerkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor
- (2010) Y. Zhao et al. CANCER RESEARCH
- Protein-glycan interactions in the control of innate and adaptive immune responses
- (2008) Yvette van Kooyk et al. NATURE IMMUNOLOGY
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now